Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

241 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
A framework for evaluating biomarkers for early detection: validation of biomarker panels for ovarian cancer.
Zhu CS, Pinsky PF, Cramer DW, Ransohoff DF, Hartge P, Pfeiffer RM, Urban N, Mor G, Bast RC Jr, Moore LE, Lokshin AE, McIntosh MW, Skates SJ, Vitonis A, Zhang Z, Ward DC, Symanowski JT, Lomakin A, Fung ET, Sluss PM, Scholler N, Lu KH, Marrangoni AM, Patriotis C, Srivastava S, Buys SS, Berg CD; PLCO Project Team. Zhu CS, et al. Among authors: pinsky pf. Cancer Prev Res (Phila). 2011 Mar;4(3):375-83. doi: 10.1158/1940-6207.CAPR-10-0193. Cancer Prev Res (Phila). 2011. PMID: 21372037 Free PMC article.
Prognostic factors for hematologic cancers.
Misra RR, Pinsky PF, Srivastava S. Misra RR, et al. Among authors: pinsky pf. Hematol Oncol Clin North Am. 2000 Aug;14(4):907-24, ix-x. doi: 10.1016/s0889-8588(05)70318-x. Hematol Oncol Clin North Am. 2000. PMID: 10949780 Review.
GSTM1, GSTT1, and GSTP1 polymorphisms and risk of advanced colorectal adenoma.
Moore LE, Huang WY, Chatterjee N, Gunter M, Chanock S, Yeager M, Welch B, Pinsky P, Weissfeld J, Hayes RB. Moore LE, et al. Cancer Epidemiol Biomarkers Prev. 2005 Jul;14(7):1823-7. doi: 10.1158/1055-9965.EPI-05-0037. Cancer Epidemiol Biomarkers Prev. 2005. PMID: 16030123 Clinical Trial.
Methods for etiologic and early marker investigations in the PLCO trial.
Hayes RB, Sigurdson A, Moore L, Peters U, Huang WY, Pinsky P, Reding D, Gelmann EP, Rothman N, Pfeiffer RM, Hoover RN, Berg CD; PLCO Trial Team. Hayes RB, et al. Mutat Res. 2005 Dec 30;592(1-2):147-54. doi: 10.1016/j.mrfmmm.2005.06.013. Epub 2005 Jul 27. Mutat Res. 2005. PMID: 16054167
Prostate cancer screening in the Prostate, Lung, Colorectal and Ovarian cancer screening trial: update on findings from the initial four rounds of screening in a randomized trial.
Grubb RL 3rd, Pinsky PF, Greenlee RT, Izmirlian G, Miller AB, Hickey TP, Riley TL, Mabie JE, Levin DL, Chia D, Kramer BS, Reding DJ, Church TR, Yokochi LA, Kvale PA, Weissfeld JL, Urban DA, Buys SS, Gelmann EP, Ragard LR, Crawford ED, Prorok PC, Gohagan JK, Berg CD, Andriole GL. Grubb RL 3rd, et al. Among authors: pinsky pf. BJU Int. 2008 Dec;102(11):1524-30. doi: 10.1111/j.1464-410X.2008.08214.x. BJU Int. 2008. PMID: 19035857 Clinical Trial.
241 results